While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such...

There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't...

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't...

While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such...

In this webinar, users will learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and...

Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public...

In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity...

Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the...

Single-cell RNA-sequencing (scRNA-seq) is widely used to study tissue heterogeneity, identify novel cell types, study pathogenic mechanisms, develop targeted therapies...

In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis (IPA), we’ll cover how to easily query inflammatory conditions...